CLINICAL_TRIALS
trial_result
· 2020-09-03
Clinical Trial Update: Neoadjuvant Ipilimumab in Prostate Cancer [Phase 2]
Summary
A Phase 2 neoadjuvant trial of ipilimumab in prostate cancer has completed enrollment and posted results as of September 3, 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-09-03